EP1478655A4 - METHODS AND MATERIALS FOR MODULATING ENaC-BETA - Google Patents
METHODS AND MATERIALS FOR MODULATING ENaC-BETAInfo
- Publication number
- EP1478655A4 EP1478655A4 EP02799996A EP02799996A EP1478655A4 EP 1478655 A4 EP1478655 A4 EP 1478655A4 EP 02799996 A EP02799996 A EP 02799996A EP 02799996 A EP02799996 A EP 02799996A EP 1478655 A4 EP1478655 A4 EP 1478655A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- beta
- materials
- methods
- enac
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34606901P | 2001-12-31 | 2001-12-31 | |
US346069P | 2001-12-31 | ||
PCT/US2002/041850 WO2003057847A2 (en) | 2001-12-31 | 2002-12-31 | METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1478655A2 EP1478655A2 (en) | 2004-11-24 |
EP1478655A4 true EP1478655A4 (en) | 2006-05-10 |
Family
ID=23357796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02799996A Withdrawn EP1478655A4 (en) | 2001-12-31 | 2002-12-31 | METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1478655A4 (en) |
AU (1) | AU2002364612A1 (en) |
WO (1) | WO2003057847A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2376400A1 (en) | 1999-06-08 | 2000-12-14 | University Of Iowa Research Foundation | Compounds and methods to enhance raav transduction |
AR066984A1 (en) | 2007-06-15 | 2009-09-23 | Novartis Ag | INHIBITION OF THE EXPRESSION OF THE ALFA SUBUNITY OF THE SODIUM EPITELIAL CHANNEL (ENAC) THROUGH ARNI (INTERFERENCE RNA) |
EA034363B1 (en) | 2010-04-23 | 2020-01-30 | Эрроухед Фармасьютикалс, Инк. | PHARMACEUTICAL COMPOSITION FOR INHIBITING BETA-ENaC GENE EXPRESSION AND USE THEREOF |
WO2013155406A1 (en) * | 2012-04-12 | 2013-10-17 | The Chinese University Of Hong Kong | Contragestion and treating inflammation by modulating sodium channel activity in the epithelium |
WO2017139381A1 (en) | 2016-02-08 | 2017-08-17 | University Of Iowa Research Foundation | Methods to produce chimeric adeno-associated virus/bocavirus parvovirus |
EA201892006A1 (en) | 2016-03-07 | 2019-04-30 | Юниверсити Оф Айова Рисерч Фаундейшн | AAV-MEDIATED EXPRESSION USING THE SYNTHETIC PROMOTER AND ENCHANSER |
US10590416B2 (en) | 2017-07-06 | 2020-03-17 | Arrowhead Pharmaceuticals, Inc. | RNAi agents for inhibiting expression of alpha-ENaC and methods of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998040516A1 (en) * | 1997-03-11 | 1998-09-17 | Yale University | Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
US20030077773A1 (en) * | 2000-12-06 | 2003-04-24 | Brandon Rhonda C. | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
-
2002
- 2002-12-31 AU AU2002364612A patent/AU2002364612A1/en not_active Abandoned
- 2002-12-31 EP EP02799996A patent/EP1478655A4/en not_active Withdrawn
- 2002-12-31 WO PCT/US2002/041850 patent/WO2003057847A2/en not_active Application Discontinuation
Non-Patent Citations (13)
Title |
---|
DATABASE NCBI 11 June 1993 (1993-06-11), XP002370531, Database accession no. L15695 * |
DATABASE NCBI 26 July 2000 (2000-07-26), XP002370524, Database accession no. AJ270360 * |
DATABASE NCBI 28 September 1999 (1999-09-28), XP002370529, Database accession no. 1QMS_A * |
DATABASE NCBI 3 October 1995 (1995-10-03), XP002370525, Database accession no. 1HAP_D * |
DATABASE NCBI 5 June 1997 (1997-06-05), XP002370532, Database accession no. Y13518 * |
DATABASE NCBI 6 March 2000 (2000-03-06), XP002370527, Database accession no. AJ132117 * |
DATABASE NCBI 7 May 1993 (1993-05-07), XP002370528, Database accession no. S85712 * |
DATABASE NCBI 7 May 1993 (1993-05-07), XP002370530, Database accession no. S81274 * |
DATABASE NCBI 7 May 1996 (1996-05-07), XP002370526, Database accession no. X87698 * |
JAIN LUCKY ET AL: "Antisense oligonucleotides against the alpha-subunit of ENaC decrease lung epithelial cation-channel activity", AMERICAN JOURNAL OF PHYSIOLOGY, vol. 276, no. 6 PART 1, June 1999 (1999-06-01), pages L1046 - L1051, XP002370512, ISSN: 0002-9513 * |
JAIN LUCKY ET AL: "Expression of highly selective sodium channels in alveolar type II cells is determined by culture conditions", AMERICAN JOURNAL OF PHYSIOLOGY, vol. 280, no. 4 Part 1, April 2001 (2001-04-01), pages L646 - L658, XP002370510, ISSN: 0002-9513 * |
MANO I ET AL: "DEG/ENAC CHANNELS A TOUCHY SUPERFAMILY THAT WATCHES ITS SALT", BIOESSAYS, CAMBRIDGE, GB, vol. 21, no. 7, July 1999 (1999-07-01), pages 568 - 578, XP008034073, ISSN: 0265-9247 * |
ZUCCHI ILEANA ET AL: "Genetic dissection of dome formation in a mammary cell line: Identification of two genes with opposing action", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 96, no. 24, 23 November 1999 (1999-11-23), pages 13766 - 13770, XP002370511, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003057847A3 (en) | 2003-12-11 |
WO2003057847A2 (en) | 2003-07-17 |
WO2003057847A8 (en) | 2004-01-15 |
AU2002364612A1 (en) | 2003-07-24 |
EP1478655A2 (en) | 2004-11-24 |
AU2002364612A8 (en) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1423120A4 (en) | 2h-phthalazin-1-ones and methods for use thereof | |
AU2002352903A8 (en) | Mesoporous materials and methods | |
GB0128287D0 (en) | Novel method and compounds | |
GB0115980D0 (en) | Apparatus and methods | |
IL158750A0 (en) | Reagents and methods for modulating dkk-mediated interactions | |
EP1434772A4 (en) | Compounds and methods | |
GB0123379D0 (en) | Modulators | |
AU2002364610A8 (en) | Methods and materials for modulating trpc4 | |
GB0111218D0 (en) | Assays methods and means | |
AU2002359694A8 (en) | Compounds and methods | |
AU2002364612A8 (en) | Methods and materials for modulating enac-beta | |
EP1379240A4 (en) | Compounds and methods | |
GB0114533D0 (en) | Substances | |
GB0115071D0 (en) | Substances | |
AU2002367320A8 (en) | Methods and materials for modulating task-3 | |
AU2002360847A8 (en) | Methods and materials for modulating p2x2 | |
GB0107628D0 (en) | Substances | |
AU2003298921A8 (en) | Methods and materials for modulating trpm2 | |
GB0116185D0 (en) | Substances | |
GB0127602D0 (en) | Materials and methods for modulating t-cell activity | |
GB0115782D0 (en) | Assays and modulators | |
AU2002254470A1 (en) | Compounds and methods | |
AU2002247441A1 (en) | Compounds and methods | |
AU2002245725A1 (en) | Compounds and methods | |
AU2002335011A1 (en) | Compounds and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040729 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060327 |
|
17Q | First examination report despatched |
Effective date: 20060726 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090701 |